2015
DOI: 10.1016/j.bbmt.2014.11.410
|View full text |Cite
|
Sign up to set email alerts
|

Safety and Efficacy of Low Dose Liposomal Amphotericin B for Prophylaxis of Invasive Fungal Infection in Hematopoietic Stem Cell Transplantation- a Single Center Experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Between February 2011–February 2012, the policy changed to 3 mg/kg × 3/week. In February 2012, following a positive report from another London institution [ 28 ] and literature review of intermittent high-dose L-AmB prophylaxis, a regimen of 7.5 mg/kg once-weekly was instituted and continues to the present day. Where antifungal prophylaxis relates to intensive chemotherapy (or a novel agent), it is usually commenced at the time of, or prior to, the first dose.…”
Section: Methodsmentioning
confidence: 99%
“…Between February 2011–February 2012, the policy changed to 3 mg/kg × 3/week. In February 2012, following a positive report from another London institution [ 28 ] and literature review of intermittent high-dose L-AmB prophylaxis, a regimen of 7.5 mg/kg once-weekly was instituted and continues to the present day. Where antifungal prophylaxis relates to intensive chemotherapy (or a novel agent), it is usually commenced at the time of, or prior to, the first dose.…”
Section: Methodsmentioning
confidence: 99%